NCT02941523 - Safety, PK and Efficacy of NOX66 as a Monotherapy and Combined With Carboplatin in Refractory Solid Tumours | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 3, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

January 10, 2019

Conditions

Cancer

Interventions

DRUG

NOX66

NOX66 administration

DRUG

Carboplatin

Carboplatin administration

Trial Locations (4)

4600

"Academician Z.Tskhakaia West Georgia National Center of Interventional Medicine LTD/ Oncology Unit- JSC EVEX Medical Corporation group member", Kutaisi

0141

Tbilisi State Medical University's First University Clinic, Department Of Oncology, Tbilisi

0186

LTD, Medulla Chemotherapy and Immunotherapy Clinic, Tbilisi

0313

JSC, Neo Medi, Tbilisi